First American Trust’s Quest Diagnostics DGX Stock Holding History

First American Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$375K	Buy	1,913 +16	+0.8%	+$3.11K	0.03%	211
2025 Q4	$329K	Hold	1,897	–	–	0.02%	224
2025 Q3	$362K	Buy	1,897 +699	+58%	+$124K	0.03%	195
2025 Q2	$215K	Buy	1,198 +1	+0.1%	+$174	0.02%	223
2025 Q1	$203K	Buy	+1,197	New	+$197K	0.02%	223
2022 Q1	–	Sell	-1,191	Closed	-$206K	–	169
2021 Q4	$206K	Buy	+1,191	New	+$181K	0.03%	156
2019 Q3	–	Sell	-3,723	Closed	-$379K	–	128
2019 Q2	$379K	Buy	3,723 +15	+0.4%	+$1.44K	0.08%	92
2019 Q1	$333K	Buy	3,708 +16	+0.4%	+$1.39K	0.07%	92
2018 Q4	$307K	Sell	3,692 -777	-17%	-$72.8K	0.08%	91
2018 Q3	$482K	Buy	4,469 +8	+0.2%	+$877	0.11%	84
2018 Q2	$490K	Buy	4,461 +16	+0.4%	+$1.67K	0.12%	91
2018 Q1	$446K	Buy	4,445 +13	+0.3%	+$1.33K	0.11%	92
2017 Q4	$436K	Buy	4,432 +17	+0.4%	+$1.61K	0.11%	89
2017 Q3	$413K	Buy	4,415 +20	+0.5%	+$2.12K	0.11%	83
2017 Q2	$489K	Buy	4,395 +14	+0.3%	+$1.48K	0.14%	83
2017 Q1	$430K	Sell	4,381 -8	-0.2%	-$763	0.13%	80
2016 Q4	$403K	Buy	4,389 +42	+1%	+$3.62K	0.12%	83
2016 Q3	$368K	Buy	4,347 +1,211	+39%	+$102K	0.11%	86
2016 Q2	$255K	Buy	3,136 +19	+0.6%	+$1.45K	0.09%	91
2016 Q1	$223K	Buy	+3,117	New	+$209K	0.08%	97

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

First American Trust's DGX Position: Q1 2026 in Review

First American Trust increased its Quest Diagnostics (DGX) stake by 0.84% in Q1 2026, buying an estimated $3.11K and bringing the position to 1,913 shares worth $375K. The position accounts for 0.03% of the portfolio, ranked #211.

First American Trust first reported a position in DGX in Q1 2016 and has held it in 20 quarters since. The position peaked at $490K in Q2 2018. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

First American Trust held 1,913 shares of Quest Diagnostics worth $375K as of Q1 2026.
First American Trust bought 16 Quest Diagnostics shares in Q1 2026, an estimated $3.11K.
Quest Diagnostics made up 0.03% of First American Trust's portfolio in Q1 2026, its #211 holding.
First American Trust first reported a position in Quest Diagnostics in Q1 2016 and has held it in 20 quarters since.
First American Trust's Quest Diagnostics position peaked at $490K in Q2 2018.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on First American Trust's 13F filing for Q1 2026, filed 12 May 2026.